Illustrative image – not actual.Sun Pharmaceutical Industries has commissioned its fourth finished medicines manufacturing unit at Dadra in western India.
The company has invested Rs.25 crore in the plant, which will manufacture tablets, capsules and dry powder inhalers. It has a capacity of 150 million units per month.
The facility is expected to cater mainly to export markets. It has been built to comply with the requirements of regulators in the US, UK and South Africa. The unit will also cater to domestic demand.
